Nasdaq: KLRA · Listed Apr 17, 2026
Kailera Therapeutics IPO
IPO price
$16.00
Kailera Therapeutics (KLRA) priced its IPO at $16.00 a share and has traded on Nasdaq since Apr 17, 2026.
KLRA today$11.62-27.38%since IPO15-min delayed · as of 7:30:03 PM EST on Nov 18, 2026
See the KLRA quoteFirst trading day · Apr 17, 2026
- IPO price
- $16.00
- the top of the range of $14 to $16
- First trade
- $26.00
- +62.50% from the IPO price
- First-day last trade
- $26.16
- +63.47% from the IPO price, regular session
- Raise
- $625M
- before the underwriters' option
These numbers are from the first trading day, Apr 17, 2026.
How KLRA did against the market
KLRA against the market, from its first trade at 1:25 ET to the last trade of the session.
- KLRA from its first trade
- +0.60%
- Against the market (QQQ)
- +0.3 pts
KLRA rose 0.6% from its first trade to the last trade of the session. That is 0.3 points better than the market.
Same-day moves do not show that KLRA caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
KLRA against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
KLRA against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Kailera Therapeutics '26 | $625M | +62.50% | +63.47% | +56.94% | +43.50% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Kailera Therapeutics IPO offers 39.06M shares to raise $625M, before any underwriters' option.
- Expected price range
- $14 to $16
- IPO price
- $16.00
- Shares offered
- 39.06M
- Money raised
- $625M
- Listing date
- Apr 17, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Kailera Therapeutics$625M
Where KLRA ranks
Kailera Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- KLRA$1.53B
KLRA news
The latest news and headlines about Kailera Therapeutics (KLRA).
- 3 Under-the-Radar Stocks to Buy and Hold for a DecadepositiveThe Motley Fool· Jun 16, 2026
- Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026positiveGlobeNewswire Inc.· Jun 5, 2026
- Is Kailera Therapeutics a Buy After Its Sizzling IPO?neutralThe Motley Fool· May 16, 2026
- Kailera Therapeutics' Strong IPO Validates "NewCo" StrategypositiveBenzinga· Apr 23, 2026
- Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharespositiveBenzinga· Apr 20, 2026
Filings and the company
What Kailera Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Kailera Therapeutics discloses to the SEC on Form 8-K.
- Quarterly earningsNov 4, 2026
On November 4, 2026, Kailera Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the quarter ended September 30, 2026.
- Bylaw amendmentApr 20, 2026
On April 20, 2026, in connection with the closing of the IPO, the amended and restated bylaws of the Company became effective. The Amended and Restated Bylaws amended and restated the Company's prior bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; and (iii) conform to the amended provisions of the Restated Certificate.
About Kailera Therapeutics
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
- Ticker
- KLRA
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- PHARMACEUTICAL PREPARATIONS
- Listed
- Apr 17, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Kailera Therapeutics IPO price?
$16.00 a share.
When did Kailera Therapeutics go public?
Kailera Therapeutics listed on Nasdaq on Apr 17, 2026 under the ticker KLRA.
How much did the Kailera Therapeutics IPO raise?
$625M, before any underwriters' option.
How did Kailera Therapeutics open on its first day?
KLRA first traded at $26.00, +62.50% from the IPO price of $16.00.
How did KLRA close on its first day?
Its last regular-session trade was $26.16, +63.47% from the IPO price of $16.00.
What was the KLRA first-day trading range?
$23.70 to $27.50 in the regular session.
How many KLRA shares traded on the first day?
7.84M shares in the regular session.
How many shares did Kailera Therapeutics sell in its IPO?
39.06M shares.
How did KLRA do against the market on its first day?
KLRA rose 0.6% from its first trade to the last trade of the session. That is 0.3 points better than the market (QQQ, the Nasdaq-100 ETF).
What exchange is KLRA listed on?
Kailera Therapeutics lists on Nasdaq under the ticker KLRA.
Build with Massive
Get the KLRA data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/KLRA/range/5/minute |
| Market cap | /v3/reference/tickers/KLRA |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.